Rare Diseases

GW Submits sNDA for CBD in Tuberous Sclerosis Complex

February 07, 2020

This additional application, supported by data from the GWPCARE6 trial, seeks to expand the indication of cannabidiol to include seizures associated with tuberous sclerosis complex.

Satralizumab BLA Accepted by FDA for Treatment of NMOSD

November 13, 2019

Study data demonstrates that treatment with satralizumab reduces risk of relapses in patients with neuromyelitis optica spectrum disorder.